Literature DB >> 19564647

Celiac disease presenting as autism.

Stephen J Genuis1, Thomas P Bouchard.   

Abstract

Gluten-restricted diets have become increasingly popular among parents seeking treatment for children diagnosed with autism. Some of the reported response to celiac diets in children with autism may be related to amelioration of nutritional deficiency resulting from undiagnosed gluten sensitivity and consequent malabsorption. A case is presented of a 5-year-old boy diagnosed with severe autism at a specialty clinic for autistic spectrum disorders. After initial investigation suggested underlying celiac disease and varied nutrient deficiencies, a gluten-free diet was instituted along with dietary and supplemental measures to secure nutritional sufficiency. The patient's gastrointestinal symptoms rapidly resolved, and signs and symptoms suggestive of autism progressively abated. This case is an example of a common malabsorption syndrome associated with central nervous system dysfunction and suggests that in some contexts, nutritional deficiency may be a determinant of developmental delay. It is recommended that all children with neurodevelopmental problems be assessed for nutritional deficiency and malabsorption syndromes.

Entities:  

Mesh:

Year:  2009        PMID: 19564647     DOI: 10.1177/0883073809336127

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  21 in total

Review 1.  Immune dysfunction in autism: a pathway to treatment.

Authors:  Milo Careaga; Judy Van de Water; Paul Ashwood
Journal:  Neurotherapeutics       Date:  2010-07       Impact factor: 7.620

2.  A case of periodic hypokalemic paralysis in a patient with celiac disease.

Authors:  Amitabh Ranjan; Pradeep K Debata
Journal:  J Clin Diagn Res       Date:  2014-06-20

3.  Differential immune responses and microbiota profiles in children with autism spectrum disorders and co-morbid gastrointestinal symptoms.

Authors:  Destanie R Rose; Houa Yang; Gloria Serena; Craig Sturgeon; Bing Ma; Milo Careaga; Heather K Hughes; Kathy Angkustsiri; Melissa Rose; Irva Hertz-Picciotto; Judy Van de Water; Robin L Hansen; Jacques Ravel; Alessio Fasano; Paul Ashwood
Journal:  Brain Behav Immun       Date:  2018-03-20       Impact factor: 7.217

Review 4.  Neurologic and psychiatric manifestations of celiac disease and gluten sensitivity.

Authors:  Jessica R Jackson; William W Eaton; Nicola G Cascella; Alessio Fasano; Deanna L Kelly
Journal:  Psychiatr Q       Date:  2012-03

5.  A review of gluten- and casein-free diets for treatment of autism: 2005-2015.

Authors:  Jennifer Harrison Elder; Consuelo Maun Kreider; Nancy M Schaefer; Mary B de Laosa
Journal:  Nutr Diet Suppl       Date:  2015-12-01

6.  Food-derived opioid peptides inhibit cysteine uptake with redox and epigenetic consequences.

Authors:  Malav S Trivedi; Jayni S Shah; Sara Al-Mughairy; Nathaniel W Hodgson; Benjamin Simms; Geert A Trooskens; Wim Van Criekinge; Richard C Deth
Journal:  J Nutr Biochem       Date:  2014-06-06       Impact factor: 6.048

7.  A nationwide study of the association between celiac disease and the risk of autistic spectrum disorders.

Authors:  Jonas F Ludvigsson; Abraham Reichenberg; Christina M Hultman; Joseph A Murray
Journal:  JAMA Psychiatry       Date:  2013-11       Impact factor: 21.596

Review 8.  Extraintestinal manifestations of coeliac disease.

Authors:  Daniel A Leffler; Peter H R Green; Alessio Fasano
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-08-11       Impact factor: 46.802

9.  Effect of gluten free diet on gastrointestinal and behavioral indices for children with autism spectrum disorders: a randomized clinical trial.

Authors:  Faezeh Ghalichi; Jamal Ghaemmaghami; Ayyoub Malek; Alireza Ostadrahimi
Journal:  World J Pediatr       Date:  2016-06-10       Impact factor: 2.764

10.  Gluten ataxia is better classified as non-celiac gluten sensitivity than as celiac disease: a comparative clinical study.

Authors:  Luis Rodrigo; Carlos Hernández-Lahoz; Eugenia Lauret; Maria Rodriguez-Peláez; Miroslav Soucek; Rachele Ciccocioppo; Peter Kruzliak
Journal:  Immunol Res       Date:  2016-04       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.